Letter | Published:

Three mutant insulins in man

Naturevolume 302pages540543 (1983) | Download Citation

Subjects

  • A Corrigendum to this article was published on 25 August 1983

Abstract

We have previously identified a structurally abnormal insulin in the serum and pancreas of a middle-aged man with diabetes mellitus1,2 which arose from a leucine for phenylalanine substitution at position 24 or 25 of the insulin B chain; further analysis of the patient's leukocyte DNA showed that one of the patient's insulin alleles had undergone mutation resulting in loss of an MboII restriction site normally present in the human insulin gene3. Two additional and unrelated patients with the same clinical syndrome have now been identified (ref. 4 and unpublished results). All of these patients showed hyperglycaemia typical of diabetes and with marked hyperinsulinaemia typical of insulin resistance, but all three show normal tolerance to exogenously administered insulin. As the opportunity of examining pancreatic tissue from patients suspected of secreting insulin variants is rare, we have developed a method combining HPLC and radioimmunoassay to identify insulin variants isolated from human sera. By this method we have shown that all three patients noted above secrete structurally variant and chemically distinct insulins. In correction of our original assignment, one is identified as [LeuB25]insulin.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Tager, H. et al. Nature 281, 122–125 (1979).

  2. 2

    Given, B. D. et al. New Eng. J. Med. 302, 129–135 (1980).

  3. 3

    Kwok, S. C. M. et al. Biochem. biophys. Res. Commun. 98, 844–849 (1981).

  4. 4

    Haneda, M. et al. Diabetes 31, (Suppl. 2), 4A (1982).

  5. 5

    Tager, H. et al. Proc. natn. Acad. Sci. U.S.A. 77, 3181–3185 (1980).

  6. 6

    Gattner, H. G., Danho, W., Behn, C. & Zahn, H. Hoppe-Seyler's Z. physiol. Chem. 361, 1135–1138 (1980).

  7. 7

    Inouye, K. et al. Experientia 37, 811–813 (1981).

  8. 8

    Wolmer, A. et al. Hoppe-Seyler's Z. physiol. Chem. 362, 581–592 (1981).

  9. 9

    Inouye, K., Watanabe, K., Tochino, Y., Kobayashi, M. & Shigeta, Y. Biopolymers 20, 1845–1858 (1981).

  10. 10

    Assoian, R. K., Thomas, N. E., Kaiser, E. T. & Tager, H. S. Proc. natn. Acad. Sci. U.S.A. 79, 5147–5151 (1982).

  11. 11

    Olefsky, J. M., Saekow, M., Tager, H. & Rubenstein, A. H. J. biol. Chem. 255, 6098–6105 (1980).

  12. 12

    Keefer, L. M. et al. Biochem. biophys. Res. Commun. 100, 1229–1236 (1981).

  13. 13

    Kobayashi, M. et al. Biochem. J. 206, 597–603 (1982).

  14. 14

    Robbins, D. C. et al. Nature 291, 679–681 (1981).

  15. 15

    Starr, J. I., Horwitz, D. L., Rubenstein, A. H. & Mako, M. E. Methods of Hormone Radioimmunoassay (eds Jaffe, B. M. & Behrman, H. L.) 613–629 (Academic, New York, 1979).

  16. 16

    Southern, E. M. J. molec. Biol. 98, 503–517 (1975).

  17. 17

    Rigby, P. W. J., Dieckmann, M., Rhodes, C. & Berg, P. J. molec. Biol. 113, 237–251 (1977).

Download references

Author information

Author notes

  1. A. Nanjo and T. Sanke: Department of Medicine, Wakayama Medical School, Wakayama City, Japan

  2. K. Inouye: Shionogi Research Laboratory, Osaka, Japan

Affiliations

  1. Departments of Biochemistry and Medicine, The University of Chicago, Cihcago, Illinois, 60637, USA

    • S. Shoelson
    • , M. Haneda
    • , P. Blix
    • , A. Nanjo
    • , T. Sanke
    • , K. Inouye
    • , D. Steiner
    • , A. Rubenstein
    •  & H. Tager

Authors

  1. Search for S. Shoelson in:

  2. Search for M. Haneda in:

  3. Search for P. Blix in:

  4. Search for A. Nanjo in:

  5. Search for T. Sanke in:

  6. Search for K. Inouye in:

  7. Search for D. Steiner in:

  8. Search for A. Rubenstein in:

  9. Search for H. Tager in:

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/302540a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.